2012-10-05 16:43:54 - Recently published research from Global Markets Direct, "Rosacea - Pipeline Review, H2 2012", is now available at Fast Market Research

Global Markets Direct's, 'Rosacea - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Rosacea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Rosacea. Rosacea - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Full Report Details at

- www.fastmr.com/prod/468401_rosacea_pipeline_review_h2_2012.aspx


Scope

* A snapshot of the global therapeutic scenario for Rosacea.
* A review of the Rosacea products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Rosacea pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Rosacea.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Rosacea pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Rosacea Overview
Therapeutics Development
An Overview of Pipeline Products for Rosacea
Rosacea Therapeutics under Development by Companies
Rosacea Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Rosacea Therapeutics - Products under Development by Companies
Rosacea Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Rosacea Therapeutics Development
Allergan, Inc.
Valeant Pharmaceuticals International
Merck & Co., Inc.
Novartis AG
Galderma S.A.
Paratek Pharmaceuticals, Inc.
Helix BioMedix, Inc.
Paloma Pharmaceuticals, Inc.
Foamix Ltd.
Gene Signal International SA.
Cutanea Life Sciences
Osaka University
Advancell
Rosacea - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
HB-1345 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
omiganan pentahydrochloride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
IDP-115 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
laropiprant - Drug Profile
Product Description
Mechanism of Action
R&D Progress
aganirsen - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Clindamycin Phosphate + Tretinoin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Calcium Dobesilate + Pulsed Dye Laser - Drug Profile
Product Description
Mechanism of Action
R&D Progress
minocycline - Drug Profile
Product Description
Mechanism of Action
R&D Progress
tetracycline - Drug Profile
Product Description
Mechanism of Action
R&D Progress
BFH-772 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Palomid 529 Topical - Drug Profile
Product Description
Mechanism of Action
R&D Progress
brimonidine tartrate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
oxymetazoline hydrochloride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
CD-5024 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SIG-990 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ANs-29 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
sirolimus - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Rosacea Therapeutics - Drug Profile Updates
Rosacea Therapeutics - Discontinued Products
Rosacea Therapeutics - Dormant Products
Rosacea - Product Development Milestones
Featured News & Press Releases
Mar 16, 2012: Galderma Completes Phase III Trials Of Investigational Drug Targeting Facial Erythema Of Rosacea

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468401&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.